Company intelligence / Profile preview

Longwood Capital

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Longwood Fund is not a therapeutics developer but a healthcare-focused venture capital firm that creates and invests in biotechnology and pharmaceutical companies developing new drugs and medical technologies.[1][3][11]

Industry: Investors

Partnerships

Co‑investments with Novartis Venture Fund through portfolio companies such as Immunitas Therapeutics and TScan Therapeutics[6]Co‑investments with Google Ventures through TScan Therapeutics[6]Co‑investments with Bayer (Leaps by Bayer) through Immunitas Therapeutics[6]Co‑investments with Evotec, M Ventures, and Alexandria Venture Investments via Immunitas Therapeutics[6]Frequent collaboration and co‑investment with Alexandria Venture Investments, as highlighted by Alexandria’s founder Joel Marcus[11]

Beyond the preview

Go deeper on Longwood Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Longwood Capital.

Explore the full profile